Suppr超能文献

Relationship between DNA ploidy and proliferative cell nuclear antigen index in canine hemangiopericytoma.

作者信息

Kang Seong-Kwi, Park Nam-Yong, Cho Ho-Sung, Shin Sung-Shik, Kang Mun-Il, Kim Sang-Ki, Hyun Changbaig, Park In-Chul, Kim Jong-Tack, Jeong Cheol, Park Sung-Hee, Park Su-Jin, Jeong Jae-Ho, Kim You-Jung, Ochiai Kenji, Umemura Takashi, Cho Kyoung-Oh

机构信息

Veterinary Medical Research Center, College of Veterinary Medicine, Chonnam National University, Gwangju, South Korea.

出版信息

J Vet Diagn Invest. 2006 Mar;18(2):211-4. doi: 10.1177/104063870601800214.

Abstract

The mitotic index is reported to be correlated with recurrence, mean patient survival, and metastasis of canine hemangiopericytoma (CHP). However, to the authors' knowledge, studies investigating the parameters that can predict recurrence or metastasis of CHP with low mitotic index have not been done. To evaluate growth kinetics of CHP with low mitotic index, a retrospective analysis of the proliferative activity by antiproliferative cell nuclear antigen monoclonal antibody and DNA contents by flow cytometry (FCM) was performed with 21 formalin-fixed and paraffin-embedded CHP samples. Of the 21 tumors evaluated by FCM, 6 (26.6%) were aneuploid tumors, and 15 (71.4%) were diploid tumors. There was significant correlation between the PCNA index and ploidy pattern. The diploid group had 39.1 +/- 9.2 PCNA index, whereas the aneuploid group's proliferative cell nuclear antigen (PCNA) index was 63.1 +/- 8.2. The diploid group had mean mitotic index value of 1.140 +/- 0.855, and the aneuploid group had a mean value of 1.067 +/- 0.767. From these results, the CHP samples with low mitotic index were classified into either the aneuploid group with higher PCNA index or the diploid group with lower PCNA index, suggesting that DNA ploidy and proliferative activity may give an indication about malignancy of CHPs with a low mitotic index.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验